Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia;Untersuchung verschiedener prognostischer Marker bei Hunden mit primärer immunhämolytischer Anämie

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 123, Issue 3-4, 2010, Pages 160-168

  Griebsch, Christine ^a   Arndt, Gisela ^b   Kohn, Barbara ^a,b  

^a Section of Neurology   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Autoimmune disease; Dogs; Prognostic markers

Indexed keywords

UREA;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; BLOOD CLOTTING; CLASSIFICATION; DOG; DOG DISEASE; EUTHANASIA; HEMAGGLUTINATION; HEMOGLOBINOPATHY; IMMUNOLOGY; MORTALITY; PHYSIOLOGY; PROGNOSIS;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; BLOOD COAGULATION; DOG DISEASES; DOGS; EUTHANASIA; HEMAGGLUTINATION; HEMOGLOBINOPATHIES; PROGNOSIS; UREA;

CANIS FAMILIARIS;

EID: 77949797714     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: 10.2376/0005-9366-123-160     Document Type: Article

References (26)

1. Burgess K, Moore A, Rand W, Cotter SM (2000): Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. JVet Intern Medl4: 456-462.
2. Carr AP, Panciera DL, Kidd L (2002): Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. JVet Intern Med 16: 504-509.
3. Cohn JN, Kowey PR, Whelton, PK (2000): New guidelines for potassium replacement in clinical practice. Arch Intern Med 160: 2429-2436.
4. Cook AK, Bertoy EH, Gregory CR (1994): Effect of oral cyclosporine (CS) in dogs with refractory immune-mediated anemia (IMA) or thrombocytopenia (ITP). JVet Intern Med 8: 170.
5. Davidow EB, Oncken A (2004): Clinical and laboratory factors associated with prognosis in IMHA cases- a prospective study. JVet Emerg Crit Care 14: S1-S17.
6. Day MJ, Mackin AJ (2008): Immune-Mediated Haematological Disease. In: Day MJ (Hrsg.), Clinical Immunology of the Dog and Cat. Manson Publishing Ltd, London, 94-106.
7. Diehl KJ (1996): Diagnosis and management of intravascular autoimmune hemolytic anemia in the dog. Vet Allergy Clin Immunol 4: 138-140.
8. Duval D, Giger U (1996): Vaccine-associated immune-mediated hemolytic anemia in the dog. JVet Intern Med 10: 290-295.
9. Engelbrecht R, Kohn B, Leibold W, Giger U (2002): Klinische Befunde, Diagnostik und Behandlungserfolge bei der primären und sekundären immunhämolytischen Anämie beim Hund. Kleintierpraxis 47: 261-328.
10. Feldmann BF (1992): Diagnostic approaches to coagulation and fibrinolytic disorders. Sem Vet Med Surg 7: 315-322.
11. Fryer JS, McMichael MA, Slater MR (2005): Effect of Heparin Use on Survival to Discharge of Dogs with Immune-Mediated Hemolytic Anemia. Proceedings of the ACVIM Congress, Baltimore (USA) 2005.
12. Jenkins TS, Black KS, Hewitt CW (1986): Treatment of autoimmune hemolytic anemia in the dog. Canine Pract 13: 39-45.
13. Klag AR, Giger U, Shofer FS (1993): Idiopathic immune-mediated hemolytic anemia in dogs : 42 cases (1986-1990). J Am Vet Med Assoc: 783-788.
14. Kohn B, Engelbrecht R, Leibold W, Giger U (2000): Klinische Befunde, Diagnostik und Behandlungserfolge bei der primären und sekundären immunbedingten Thrombozytopenie beim Hund. Kleintierprax 45: 893-907.
15. Kohn B, Giger U (2006): Hämolytische Anämien (HA). In: Suter PF und Kohn B (Hrsg.), Praktikum der Hundeklinik. Parey, Stuttgart, 593-596.
16. Kohn B, Weingart C, Eckmann V, Ottenjann M, Leibold W (2006): Primary immune-mediated hemolytic anemia in 19 cats: diagnosis, therapy, and outcome (1998-2004). J Vet Intern Med 20(1): 159-166.
17. McManus PM, Craig LE (2001): Correlation between leukocytosis and necropsy findings in dogs with immune-mediated haemoIytic anemia: 34 cases (1994-1999). J Am Vet Med Assoc 218(8): 1308-1313.
18. Mischke R, Wohlsein P, Busse L (1998): Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasized mammary carcinoma. Schweiz Arch Tierheilkd 140: 497-505.
19. Opdenakker G, Fibbe WE, Van Damme J (1998): The molecular basis of leukocytosis. Immunol. Today 19: 182-189.
20. Piek CJ, Junius G, Dekker A, Schrauwein E, Slappendel RJ, Teske E (2008): Idiopathic immune-mediated haemolytic anemia: treatment outcome and prognostic factors in 149 dogs. JVet Intern Med 22: 366-373.
21. Reimer ME, Troy GC, Wamick LD (1999): Immune-mediated hemolytic anemia: 70 cases (1988-1996). J Am Anim Hosp Assoc 35: 384-391.
22. Scott-Moncrieff JC, Treadwell NG, McCullough SM, Brooks MB (2001): Hemostatic abnormalities with primary immune mediated haemolytic anemia. J Am Anim Hosp Assoc 37: 220-227.
23. Slappendel RJ (1988): Disseminated intravascular coagulation. Vet Clin North Am Small Anim Pract 18:169-184.
24. Switzer JW, Jain NC (1981): Autoimmune hemolytic anemia in dogs and cats. Vet Clin North Am Small Anim Pract 11: 405-419.
25. Weinkle TK, Center SA, Randolph JF, Warner KL, Barr SC, Erb HN (2005): Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc 226 (11): 1869-1880.
26. Weiss DH (1984): Uniform evaluation and semiquantitative reporting of hematologic data in veterinary laboratories. Vet Clin Pathol 13: 27-31.